Cargando…
Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients
BACKGROUND: Hepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening...
Autores principales: | Wong, Xue Zheng, Gan, Chye Chung, Mohamed, Rosmawati, Yahya, Rosnawati, Ganapathy, Shubash, Tan, Soek Siam, Lim, Soo Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666439/ https://www.ncbi.nlm.nih.gov/pubmed/33187498 http://dx.doi.org/10.1186/s12882-020-02154-4 |
Ejemplares similares
-
Hepatitis C diagnosics: clinical evaluation of the HCV-core antigen determination
por: van Helden, Josef
Publicado: (2014) -
Genetic diversity of hepatitis B co-infection with hepatitis C, D and E viruses among Malaysian chronic hepatitis B patients
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2018) -
Role of hepatitis C virus core antigen assay in hepatitis C care in developing country
por: Kallala, Ouafa, et al.
Publicado: (2021) -
Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C
por: Radzi AH, Muhammad, et al.
Publicado: (2018) -
The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice
por: Torbati, Elham, et al.
Publicado: (2012)